Nomic Bio Revenue and Competitors

Location

$59M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nomic Bio's estimated annual revenue is currently $4M per year.(i)
  • Nomic Bio's estimated revenue per employee is $49,146
  • Nomic Bio's total funding is $59M.

Employee Data

  • Nomic Bio has 82 Employees.(i)
  • Nomic Bio grew their employee count by 67% last year.

Nomic Bio's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
Head AutomationReveal Email/Phone
4
Director Process DevelopmentReveal Email/Phone
5
Sr. Technical Sales ManagerReveal Email/Phone
6
Technical Product ManagerReveal Email/Phone
7
Technical Sales ManagerReveal Email/Phone
8
Customer Success Operations ManagerReveal Email/Phone
9
Senior Field Applications ScientistReveal Email/Phone
10
Associé opérations (Profiling)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.9M1813%$150.5MN/A
#2
$28.4M183-56%N/AN/A
#3
N/A1025%N/AN/A
#4
$4.3M21-9%N/AN/A
#5
$55.6M3591%N/AN/A
#6
$11M570%N/AN/A
#7
$22.2M143-22%N/AN/A
#8
$4.2M2713%N/AN/A
#9
$2M1427%N/AN/A
#10
$295.7M176313%N/AN/A
Add Company

What Is Nomic Bio?

Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.

keywords:N/A

$59M

Total Funding

82

Number of Employees

$4M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.5M829%N/A
#2
$18M82N/AN/A
#3
$12M823%N/A
#4
$17.2M82-2%N/A
#5
$13.1M82-4%N/A